Lessons from COVID-19: how can vaccine clinical trials adapt to emerging threats?

In this interview, Charlotte Barker, Editor, Vaccine Insights, speaks to Daniel Hoft, PI of the Vaccine and Treatment Evaluation Unit, Saint Louis University (SLU) School of Medicine, about improving pandemic preparedness and the key role of human challenge trials.

Please enter your email to access content Read now